Clinical trialNCT05107674RecruitingPhase 1Interventional

A Study of NX-1607 in Adults With Advanced Malignancies

SponsorNurix Therapeutics, Inc.Enrollment345Cervical CancerDiffuse Large B Cell Lymphoma (DLBCL)Gastric CancerGastroEsophageal Junction (GEJ) CancerHead and Neck Squamous Cell CarcinomaMalignant Pleural Mesothelioma (MPM)+8 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Linda Neuman, MD
Nurix Therapeutics, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United Kingdom

Royal Marsden Hospital Nhs Foundation Trust
Sutton, Surrey, United Kingdom
Recruiting
Addenbrookes Cambridge University Hospital
Cambridge, United Kingdom
Recruiting
Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom
Recruiting
Sarah Cannon Research Institute
London, United Kingdom
Recruiting
the Christie Nhs Foundation Trust
Manchester, United Kingdom
Recruiting
Northern Centre for Cancer Care
Newcastle, United Kingdom
Recruiting
Churchill Hospital
Oxford, United Kingdom
Completed

United States

City of Hope
Duarte, California, United States
Completed
University of Southern California
Los Angeles, California, United States
Recruiting
University of California, San Francisco
San Francisco, California, United States
Recruiting
University of Colorado School of Medicine
Aurora, Colorado, United States
Wells Messersmith, MD
Recruiting
University of Chicago
Chicago, Illinois, United States
Recruiting
University of North Carolina
Chapel Hill, North Carolina, United States
Recruiting
University of Oklahoma
Oklahoma City, Oklahoma, United States
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Recruiting
University of Virginia
Charlottesville, Virginia, United States
Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 29 Sept 2021
Primary completion: 31 Aug 2026
Completion: 28 Feb 2028
Last update posted: 9 Sept 2025
Registered enrollment: 345
Registry id: NCT05107674

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.